Skip to main content

Anika Therapeutics, Inc 10-Q for FY2025 Q3

Anika Therapeutics, Inc. (ANIK)

10-Q 2025-11-05 For: 2025-09-30
View Original
Added on April 06, 2026

About this 10-Q

Anika Therapeutics, Inc filed this 10-Q on November 5, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$27.82M
down 5.9% from $29.56M a year earlier
Net loss
$2.33M
compared with a net loss of $29.92M a year earlier
Diluted EPS
-$0.16
compared with -$2.03 a year earlier